Breakthroughs in Pancreatic Cancer Treatment

Can a New Drug Candidate Cure Pancreatic Cancer? - UCSF

The new drug candidate permanently modifies a wily cancer-causing mutation, called K-Ras G12D, that is responsible for nearly half of all ...

Advances in Pancreatic Cancer Research - NCI

New treatments for metastatic pancreatic cancer that are being investigated in clinical trials include immunotherapy and targeted therapy.

Breakthroughs in Pancreatic Cancer Treatment - UC Health

This article aims to unfold the latest advances and explore how they're rewriting the narrative of pancreatic cancer treatment.

Advancements in Pancreatic Cancer Vaccines: A New Frontier in ...

The landscape of pancreatic cancer treatment is evolving, driven by innovative approaches such as immunotherapy and pancreatic cancer vaccines.

Potential New Therapies Help Outsmart Pancreatic Cancer

For example, advances in immunotherapy are changing the way doctors treat pancreatic cancer. In clinical trials, doctors use a novel pancreatic cancer ...

Opening a New Front Against Pancreatic Cancer

A new type of investigational therapeutic in development for pancreatic cancer has shown unprecedented tumor-fighting abilities in preclinical models of the ...

New Pancreatic Cancer Treatment Proves Effective in Shrinking ...

Researchers at the University of Massachusetts Amherst and UMass Chan Medical School have demonstrated in mice a new method to combat pancreatic cancer.

Investigational mRNA Vaccine Induced Persistent Immune ...

An experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate autogene ...

The Promising Pancreatic Cancer Vaccine Clinical Trial - UC Health

The promising new mRNA vaccine trial offers a significant breakthrough in pancreatic cancer treatment, showing hope against the highest ...

Breakthrough for pancreatic cancer treatment - Drug Target Review

Researchers have designed the first small molecule drug targeting K-Ras GD12, which could improve pancreatic cancer outcomes.

FDA Approves New First-line Treatment Option for Metastatic ...

NALIRIFOX has been approved by the FDA as a new first-line treatment for metastatic pancreatic cancer. This means patients whose cancer has ...

State of the Union: Pancreatic Care in 2024 | Columbia Surgery

We now have a vaccine, a clinical trial is available to treat people who have operable or resectable pancreatic cancer. And we just enrolled our first patient ...

Study Reveals Potential Immunotherapy Advance for Pancreatic ...

A new study published in the peer-reviewed journal Cancer Letters uncovered information about how the immune system can recognize and kill cancer cells.

Chemo Boosts KRAS Inhibitor Against Pancreatic Cancer - NCI

A newer class of drugs that target pancreatic cancer may get a helping hand from an old treatment workhorse: chemotherapy.

Pancreatic Cancer Discovery Opens the Door for New Clinical Trial ...

In their latest work, Wilmot researchers built on what was already known about a key gene, Netrin-1, involved in pancreas, breast and colon ...

A Rare Story of Hope in Pancreatic Cancer Treatment

A clinical trial based on discoveries made by researchers in Columbia's Pancreas Center is showing promising results and is now expanding to ...

New Pancreatic Cancer Research Breakthrough

One of our researchers has identified a potential new treatment target for pancreatic cancer. Dr Miriam Martini, based in Torino, Italy, recently made this ...

Recent advances in understanding pancreatic cancer - PMC

Pancreatic ductal adenocarcinoma (PDAC) is an intractable cancer and a leading cause of cancer deaths worldwide. Over 90% of patients die within 1 year of ...

Scientists make DNA discovery that could help find pancreatic ...

A team of researchers from the UK and US have found that pancreatic cancer is able to shut down molecules in one of the body's most important genes.

Leading the revolution in pancreatic cancer - AstraZeneca

With the emergence of genomic profiling technologies, and selective molecular targeted therapies, biomarkers have now been shown to play an increasingly ...